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abstract
 
Site-3 toxins isolated from several species of scorpion and sea anemone bind to voltage-gated Na
channels and prolong the time course of I
 
Na
 
 by interfering with inactivation with little or no effect on activation,
effects that have similarities to those produced by genetic diseases in skeletal muscle (myotonias and periodic pa-
ralysis) and heart (long QT syndrome). Some published reports have also reported the presence of a noninactivat-
ing persistent current in site-3 toxin-treated cells. We have used the high affinity site-3 toxin Anthopleurin B to
study the kinetics of this current and to evaluate kinetic differences between cardiac (in RT4-B8 cells) and neu-
ronal (in N1E-115 cells) Na channels. By reverse transcriptionÐPCR from N1E-115 cell RNA multiple Na channel
transcripts were detected; most often isolated were sequences homologous to rBrII, although at low frequency se-
quences homologous to rPN1 and rBrIII were also detected. Toxin treatment induced a voltage-dependent pla-
teau current in both isoforms for which the relative amplitude (plateau current/peak current) approached a con-
stant value with depolarization, although the magnitude was much greater for neuronal (17%) than cardiac (5%)
I
 
Na
 
. Cell-attached patch recordings revealed distinct quantitative differences in open times and burst durations be-
tween isoforms, but for both isoforms the plateau current comprised discrete bursts separated by quiescent peri-
ods, consistent with toxin induction of an increase in the rate of recovery from inactivation rather than a modal
failure of inactivation. In accord with this hypothesis, toxin increased the rate of whole-cell recovery at all tested
voltages. Moreover, experimental data support a model whereby recovery at negative voltages is augmented
through closed states rather than through the open state. We conclude that site-3 toxins produce qualitatively sim-
ilar effects in cardiac and neuronal channels and discuss implications for channel kinetics.
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introduction
 
Insights into the molecular basis of Na channel inacti-
vation have been achieved through a combination of
targeted structure/function studies (Fozzard and Hanck,
1996) and investigation of natural mutagenesis in a va-
riety of genetic diseases that target Na channel inactiva-
tion in skeletal muscle (e.g., myotonias and periodic
paralysis; Cannon, 1996) and the heart (long QT syn-
drome; Ackerman, 1998). Another important tool for
increasing our understanding of inactivation in Na
channels is the family of site-3 toxins (Catterall, 1980),
which comprise a structurally diverse group of peptide
toxins isolated from several species of scorpion (Catter-
all, 1977; Wang and Strichartz, 1983) and sea anemone
(Narahashi et al., 1969; Bergman et al., 1976; Romey
et al., 1976). These toxins bind to the extracellular face
of voltage-gated Na channels and prolong the time
course of sodium current (I
 
Na
 
) by interfering with
channel inactivation (Narahashi et al., 1969; Bergman
et al., 1976; Romey et al., 1976). Single-channel studies
(Schreibmayer et al., 1987; Nagy, 1988; Kirsch et al.,
1989; El-Sherif et al., 1992) and whole-cell studies
(Hanck and Sheets, 1995) suggest that the prolonga-
tion of current arises from a selective inhibition of
channel inactivation from the open state, O
 
 ® 
 
I, with
little effect on the activation process or on inactivation
from closed states (C
 
 ® 
 
I), and a gating current study
in cardiac channels demonstrated that toxin binding
eliminates the charge movement associated with O 
 
« 
 
I
transitions (Sheets and Hanck, 1995).
It is unlikely that the binding of toxin alters only a
single rate constant if this rate constant were located in
a kinetic loop, since such a modification would violate
microscopic reversibility. In addition, ionic current
studies have reported that toxin induces a low-ampli-
tude noninactivating current (Bergman et al., 1976; Sie-
men and Vogel, 1983; Gonoi et al., 1984; Wasserstrom
et al., 1993), as reflected by the failure of steady state
availability relations to reach zero, even at positive po-
tentials. More interestingly, several studies using scor-
 
Portions of this work were previously published in abstract form
(Benzinger, G.R., and D.A. Hanck. 1997. 
 
Biophys. J. 
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pion toxins have noted a noninactivating current com-
ponent that increased in magnitude with increasing
depolarization (Koppenhofer and Schmidt, 1968;
Mozhayeva et al., 1980; Wang and Strichartz, 1985).
That is, steady state availability reached a nadir at an in-
termediate voltage and increased with further depolar-
ization. Conversely, other investigations have reported
steady state availability relations that suggest that volt-
age-dependent inactivation is complete (Hanck and
Sheets, 1995).
The lack of agreement between studies about the
presence and the magnitude of a plateau current could
be due to the differences among channel isoforms
studied. Neuronal Na channel isoforms have an O
 
 ® 
 
I
inactivation rate constant that is largely voltage inde-
pendent (Aldrich et al., 1983; Vandenberg and Beza-
nilla, 1991). On the other hand, open-state inactivation
in cardiac channels is voltage dependent (Berman et al.,
1989; Yue et al., 1989; Scanley et al., 1990) and is ac-
companied by a gating charge movement that is immo-
bilized by site-3 toxins (Sheets and Hanck, 1995). Dif-
ferences in the observed effects of toxins may, therefore,
be secondary to kinetic differences in the channels they
modify. Alternately, the observed biphasic availability
relations might be peculiar to scorpion toxins. Finally,
differences might reflect specific discrepancies in the
voltage protocols and analysis methods used.
In these experiments, we studied the kinetic mecha-
nisms underlying this plateau current. In particular, we
tested whether the noninactivating current arose from
a change in single-channel conductance, a persistent
rate of recovery from inactivation, or a toxin-induced
modal shift in channel gating. To address the issue of
channel isoform specificity, we recorded from neu-
ronal channels expressed in the neuroblastoma cell
line N1E-115 and from cardiac channels expressed in
the cell line RT4-B8 (Zeng et al., 1996). 
 
methods
 
Cells and Cell Culture
 
Cells were grown in DulbeccoÕs Modified EagleÕs Medium
(GIBCO BRL) supplemented with 9% fetal bovine serum and
were maintained at 37
 
8
 
C in a humid atmosphere containing 5%
CO
 
2
 
. Before recording, cells were dissociated from their sub-
strate by brief (
 
,
 
2 min) digestion in a solution containing 0.25%
trypsin with 1 mM EDTA. Cardiac I
 
Na
 
 was recorded from the rat
peripheral neurotumor cell line RT4-B8, which has been shown
to express the cardiac isoform exclusively (Donahue et al., 1991;
Zeng et al., 1996). Neuronal I
 
Na
 
 was recorded from the murine
neuroblastoma cell line N1E-115. We used reverse transcription
(RT)ÐPCR analysis to determine the channel isoforms present in
this cell line.
 
RT-PCR and Sequence Analysis
 
Total RNA was isolated from N1E-115 cells using the RNeasy To-
tal RNA System (QIAGEN Inc.). RNA was then treated with pan-
creatic DNase I (Stratagene Inc.) to remove any contaminating
genomic DNA. cDNA was generated by reverse transcription us-
ing MuLV Reverse Transcriptase (Perkin-Elmer Corp.) as previ-
ously described (Zeng et al., 1996). PCR amplification was car-
ried out using 1.75 U Expand High Fidelity polymerase enzyme
mix (Hoffman-La Roche) with a reaction mixture containing 10
mM Tris-HCl, pH 8.3, 50 mM KCl, 2.25 mM MgCl
 
2
 
, 2% (vol/vol)
DMSO, 0.1% Tween-20, and 1 
 
m
 
M primers as in Dib-Hajj et al.
(1996). Five primer sets were selected that would detect various
Na channel 
 
a
 
 subunits (Table I). Primer sets 1 and 2, which span
a portion of domain IV, S5-S6, are identical to ones used by Dib-
Hajj et al. (1996). Primer set 1 recognizes isoforms (with Gen-
bank accession numbers) rBrI (X03638), rBrII (X03639), rBrIII
(Y00766), mNa6 (U26707), rPN1 (U79568), mSNS (Y09108),
and rSkm1 (M26643). Primer set 2 recognizes mNav2.3
(L36179), hNav2.1 (M91556), and SCL11 (Y09164). Primer set 3
recognizes sequences upstream of domain I and extends to the
middle of domain I S5 in all rat brain isoforms plus mNa6. A
primer set specific to glyceraldehyde-3-phosphate dehydrogenase
(GAPDH)
 
1 
 
was included as a positive control in each PCR reac-
tion. Although these primers were originally designed based on
rat GAPDH (Genbank X02231), mouse sequence and primers
would be identical except for the 5
 
9
 
 base of the reverse primer.
For each primer set, a reaction that contained all of the reaction
components except cDNA (primer only) was also run as a nega-
tive control. Using an ABI automatic sequencer, purified PCR-
generated fragments were sequenced directly or were first sub-
cloned into the pCRII vector (Invitrogen Corp.).
 
Electrophysiology
 
For whole-cell recordings, the bath solution contained (mM) 140
Na
 
1
 
, 2 Ca
 
2
 
1
 
, 144 Cl
 
2
 
, 10 HEPES. To verify accuracy of the mea-
surement of plateau currents, in a few whole-cell experiments
130 Mes
 
2
 
 was substituted for 130 Cl
 
2
 
 to eliminate an endogenous
Cl
 
2
 
 current that had been observed in a few N1E-115 cells; no
differences in Na channel kinetics were observed with this substi-
tution. The pipette solution contained (mM) 140 Cs
 
1
 
, 10 Na
 
1
 
,
100 F
 
2
 
, 50 Cl
 
2
 
, 10 HEPES, set to pH 7.3 with CsOH. Pipette resis-
tances were typically 0.8Ð1.2 M
 
V
 
. After high-resistance seals were
achieved, cells were lifted from the bottom of the bath and trans-
ferred to a chamber containing bath solution supplemented
(when applicable) with saturating concentrations of Anthopleu-
rin B toxin (ApB) and 5 mg/ml bovine serum albumin (to pre-
vent toxin adherence to tubing). Typically, 100 nM toxin was
used with cardiac channels (
 
K
 
d
 
 
 
5 
 
0.9 nM; Khera et al., 1995),
and 300Ð600 nM toxin was used with neuronal channels (
 
K
 
d
 
 
 
5
 
5.1 nM; Khera et al., 1995) ApB was a kind gift of K. Blumenthal
(University of Cincinnati, Cincinnati, OH). Toxin modification
was monitored by the appearance of prolonged I
 
Na
 
 in response to
depolarization, and experiments proceeded when modification
was complete. To ensure full channel availability, holding poten-
tial was set to 
 
2
 
150 (cardiac) or 
 
2
 
130 (neuronal) mV.
For single-channel cell-attached recordings, the bath solution
contained (mM) 140 K
 
1
 
, 2 Ca
 
2
 
1
 
, 144 Cl
 
2
 
, 10 HEPES, which de-
polarized the membrane potential to 
 
z
 
0 mV so that pipette po-
tentials did not require correction. The pipette solution con-
tained (mM) 280 Na
 
1
 
, 2 Ca
 
2
 
1
 
, 284 Cl
 
2
 
, 10 HEPES (some early ex-
periments used 140 Na
 
1
 
 and 144 Cl
 
2
 
), set to pH 7.3 with CsOH.
Pipette resistances were typically 2Ð10 M
 
V
 
, with the lower resis-
tances used for patches exposed to toxin to increase the number
 
1
 
Abbreviations used in this paper:
 
 ApB, Anthopleurin B toxin; GAPDH,
glyceraldehyde-3-phosphate dehydrogenase; RT-PCR, reverse tran-
scriptionÐPCR. 
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of channels/patch. Pipettes were heat polished, and tips were
painted with Sylgard 182 (Dow Corning Corp.) or sticky wax
(Kerr). We found it difficult to obtain high-resistance seals in the
presence of high toxin concentrations. Therefore, in experi-
ments requiring toxin, the tip of the pipette was filled with toxin-
free solution by capillation, and the remainder of the pipette was
back-filled with pipette solution supplemented with 1 
 
m
 
M ApB.
Toxin modification was monitored by the appearance of late
channel reopenings and typically occurred within 2Ð10 min of es-
tablishing a membrane seal.
Voltage protocols were generated using pClamp 6.0.3 (Axon
Instruments) and imposed by an Axopatch 200B (Axon Instru-
ments) amplified through a Labmaster TL-1 digital-to-analog
convertor. Current waveforms were filtered at 10 (whole cell) or
2 (single channel) kHz, digitized at 50 (whole cell), 25 (single
channel, control), or 10 (single channel, toxin) kHz with 12-bit
resolution, and stored on an MS-DOSÐbased computer (Gateway
2000). Temperature was controlled with a TS-4 controller (Sen-
sortek). To resolve single-channel events, the rapid phase of I
 
Na
 
recovery, and tail current time course with high accuracy, we car-
ried out all experiments at 6
 
8
 
C. Grouped data are reported as
means 
 
6
 
 SEM.
 
Analysis
 
Whole-cell and single-channel data were analyzed using locally
written software in Matlab 5.1 (The MathWorks). For whole-cell
data, traces were ohmically leak corrected based on the current
at the holding potential, capacity corrected on the basis of 100
summed subthreshold pulses (20 mV each), and digitally refil-
tered at 5 kHz using a zero-phase filtering algorithm. Single-
channel traces were capacity corrected based on the average of
null sweeps and baseline-corrected by eye. Traces were idealized
using a half-amplitude criterion and checked for accuracy by eye.
For toxin-modified patches, late reopenings were defined as
openings commencing later than 100 ms after depolarization on-
set and occurring subsequent to a period of at least 15 ms at the
null current amplitude. As in previous single channel studies
with site-3 toxins, occasional subconductance events were noted
(Nagy, 1987; El-Sherif et al., 1992), and sweeps displaying such
activity were excluded from kinetic analyses.
 
results
 
Na Channel Expression in N1E-115 Cells 
 
The cell line N1E-115 has been a traditional prepara-
tion for the evaluation of mammalian neuronal I
 
Na
 
(e.g., Aldrich et al., 1983; Goldman, 1995), and has also
been studied with respect to site-3 toxins (Khera et al.,
1995). To characterize the channel isoforms present in
this cell line, we performed RT-PCR experiments using
primer sets complementary to a variety of known Na
channel 
 
a
 
 subunits. Primer sets 1 and 3 and the posi-
tive GAPDH control (Table I) produced the expected
size PCR products (data not shown). No PCR products
were detected using the primer set specific for the
mNav2.3, hNav2.1, or SCL11 sodium channel isoforms
(primer set 2). Except for mNa6, mSNS, and mNav2.3,
full cDNA sequences for most mouse channel isoforms
were not available. For these, we performed sequence
alignments against the rat Na channel 
 
a
 
 subunits. From
11 subcloned fragments from primer sets 1 and 3, six
sequences were most homologous to rBrII (
 
.
 
90%),
two to rPN1 (
 
.
 
93%), and one to rBrIII (90%). The re-
maining two subcloned fragments were 
 
,
 
68% homolo-
gous to any of the reference sequences but were most
similar to rBrI. Excepting rBrI, sequences homologous
to the above listed isoforms were also detected from the
direct sequencing of the PCR-generated fragments.
 
table i
 
RT-PCR Primer Sets Used to Identify Na Channel Isoforms Present in N1E-115 Cells
 
Set Isoforms Sequence Location* Size
 
à
 
rBrI, rBrII,
rBrIII, mNa6, F 5
 
9
 
 CTGCTCTTCCTGGTCATGTTCATC 5206 (rBrII)
1 298
rPN1, mSNS, R 5
 
9
 
 GGAAGGATATGATGATGTAGCTGACAAA 5503 (rBrII)
rSkm 1
mNav2.3, F 5
 
9
 
 CTGCTCTTCCTGGTCATGTTCATC 4407 (mNav2.3)
2 hNav2.1, 300
R 5
 
9
 
 CAACCATGATATGAGGATGTAACTGACA 4706 (mNav2.3)
SCL11,
F 5
 
9
 
 AC (T,C) TC (T,C) GCCCTGTA (C,T) ATTTTAACTCC 526 (rBrII)
rBrI, rBrII,
3 460
rBrIII, mNa6
R 5
 
9
 
 GACAGAACACGGTGAGGATCATGACG 985 (rBrII)
F 5
 
9
 
 GACCCCTTCATTGACCTCAACTAC 168 (GAPDH)
4 GAPDH 408
R 5
 
9
 
 GATGCCAAAGTTGTCATGGATGAC 575 (GAPDH)
*The location of each primerÕs 5
 
9
 
 end is given with reference to the noted isoformÕs numbering as it appears in Genbank. 
 
à
 
Size of expected product,
given in base pairs. 
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N1E-115 cells therefore represent an appropriate vehi-
cle for the study of mammalian neuronal I
 
Na
 
.
 
Isoform Dependence of Plateau Current
 
Consistent with previous results (e.g., Catterall, 1980;
Strichartz et al., 1987), cardiac and neuronal I
 
Na
 
 dis-
played dramatically prolonged decay in the presence of
saturating toxin concentrations. At the conclusion of
this decay, however, a significant plateau current per-
sisted throughout the 2-s test pulses (Fig. 1, A and B).
This current was dependent on voltage and differed in
magnitude with isoform, ranging from 5 
 
6 
 
1% of the
peak amplitude in cardiac channels to 17 
 
6 
 
3% of the
peak amplitude in neuronal channels (Fig. 1, C and D).
Despite the differences in magnitude, the voltage de-
pendencies of the plateau currents as evaluated in con-
ductance transforms were similar to that for peak cur-
rents (Fig. 1, E and F).
Steady state voltage-dependent availability was as-
sessed using a uniform protocol with 2-s conditioning
times for both cardiac and neuronal I
 
Na
 
. This time was
chosen because it is standard for the cardiac isoform,
and although much longer than is typical in the litera-
ture for conditioning neuronal channels, gives similar
results to shorter conditioning times (Fozzard and
Hanck, 1996). Availability protocols in the presence of
toxin yielded currents with complex waveforms. In neu-
ronal channels (Fig. 2), test pulses to 
 
1
 
20 mV after
negative conditioning steps produced currents with
time courses appropriate to activation of toxin-modi-
fied channels from closed states (time to peak, 2.8 
 
6
 
0.1 ms). After conditioning at intermediate voltages,
depolarization to the test potential produced a current
Figure 1. Site-3 toxins induce a
persistent Na1 current. Cells
were modified to completion
with saturating doses of ApB. (A)
Cardiac INa in response to depo-
larization to 210 mV; traces
show INa before (top) and after
(bottom) toxin modification. In-
set shows expanded time scale.
Arrow denotes the time at which
plateau currents were measured
for use in conductance calcula-
tions (cell 97n10044, Rm  5  0.6
GV). (B) Neuronal INa in re-
sponse to depolarization to 120
mV, as above (cell 98209008, Rm
5 0.8 GV). Currents were leak-
and capacity-corrected as de-
scribed in methods. (C) Peak
(d) and steady state (n) cur-
rentÐvoltage relations for cardiac
channels, normalized by the
peak current at 210 mV (n 5 4).
(D) Peak (d) and steady state
(n) currentÐvoltage relations for
neuronal channels, normalized
by the peak current at 120 mV
(n 5 7). (E) ConductanceÐvolt-
age relations of cardiac INa. Re-
versal potentials were con-
strained to those predicted by pi-
pette and bath solutions. Fits to
peak and steady state currentÐ
voltage relations with the prod-
uct of the Boltzmann equation
and OhmÕs law yielded the fol-
lowing values. Peak half-point,
235 6 3 mV; peak slope, 27.3 6
1.1 mV; plateau half-point, 236
6 2 mV; plateau slope, 27.4 6 0.7 mV. For illustrative purposes, normalized currentÐvoltage data were conductance-transformed by
OhmÕs law and normalized by the maximal conductance of peak current. Inset shows the plateau current independently normalized to
1.0. (F) ConductanceÐvoltage relations of neuronal INa, as above. Peak half-point, 214 6 2 mV; peak slope, 28.3 6 0.2 mV; plateau half-
point, 213 6 2 mV; plateau slope, 26.4 6 0.5 mV.337 Benzinger et al.
that started at zero magnitude and developed mono-
tonically with a time course much slower than that typi-
cal of channel activation, reaching a plateau (reflecting
the steady state current at Vt 5 120 mV) by z40 ms. Af-
ter conditioning at positive potentials, current was
present immediately upon shifting to the test potential,
as expected from the presence of the plateau current
during the conditioning pulse and the ohmic change
in driving force. These data were similar to those found
with scorpion toxin in toad axons (Wang and Stri-
chartz, 1985).
Depending on the window used for searching for
peak currents and the conditioning potential em-
ployed, the steady state availability relationship would
contain varying contributions from all three of these
components: activation, slowly developing plateau cur-
rent, and already-present plateau current. To calculate
the contribution of that fraction of channels open at
the end of the conditioning pulse (Fig. 2), we mea-
sured current at an isochrone immediately after the on-
set of the test pulse. This relationship was sigmoidal
with a half-point and voltage dependence that matched
the conductance relationship of the plateau currents
measured in long depolarizations. Currents measured
at an isochrone corresponding to the time to peak of
INa for activation from a fully available conditioning po-
tential comprised both the instantaneous plateau cur-
rent measured at the earlier time and the activation of
channels that remained closed and available, although
this time point was still early enough to minimize the
contribution of inactivated channels slowly Òrecover-
ingÓ at the test potential of 120 mV. The difference be-
tween these two curves, therefore, reflects the Òtradi-
tionalÓ availability relationship arising from the inacti-
vation of channels during the conditioning pulse. This
relationship and the absence of current immediately af-
ter the step to 120 mV from intermediate voltages indi-
cate that channels equilibrate completely into inacti-
vated states at intermediate depolarizations (e.g., 230
mV in Fig. 2 B), but that the inactivated states are in-
completely absorbing at more positive voltages.
Cardiac INa displayed an essentially similar, biphasic
steady state availability, but the smaller amplitude of
the plateau current in this isoform made this behavior
more difficult to appreciate. Isochronal steady state
availability relations at the time to peak of activation of
fully available channels are compared with peak avail-
ability relations of control channels for both isoforms
in Fig. 3.
Kinetic Basis of Plateau Current
In principle, the plateau current could occur in several
ways. First, the toxin might modify the channelsÕ gating
kinetics such that the inactivated state at positive poten-
tial was not completely absorbing, as suggested in a
study in toad myelinated nerve (Wang and Strichartz,
1985). Second, the toxin might induce a (voltage-depen-
dent) fraction of the channels to fail to inactivate com-
pletely, yielding a persistent current. Such a modal fail-
ure of inactivation has been observed at low frequency
in several mammalian Na channel isoforms (e.g., Patlak
and Ortiz, 1985; Alzheimer et al., 1993) and has been
proposed as the mechanism of disease in some human
myotonias (see Cannon, 1996). It has also been sug-
gested for the mode of action of toxin II from Anemonia
sulcata in skeletal muscle (Cannon and Corey, 1993).
In short, persistent recovery might occur in all the
channels some of the time, or in some of the channels
all of the time. Finally, toxin binding might affect the
single-channel conductance of modified channels.
Figure 2. Steady state availability protocol for neuronal Na chan-
nels. (A) Sample currents are shown during a test pulse to 120 mV
after a 2-s conditioning pulse to (A) 130 mV, (B) 220 mV, and
(C) 2140 mV. Inset shows the beginning of the current on an ex-
panded time scale. Vertical lines denote the time points used in
calculating average availability relations. (B) Relative availability is
shown for currents recorded shortly after test pulse onset (j) and
at the time to peak of currents after negative conditioning pulses
(n). The difference between these currents (d) is also shown. All
currents were normalized by the peak current magnitude at nega-
tive potentials. Inset shows voltage protocol. Cardiac channels be-
haved similarly, but with a much smaller plateau current (see Fig.
3) (n 5 3).338 Site-3 Toxins Augment Recovery of Na Channels
Previous single channel studies with site-3 toxins in a
variety of preparations have not reported changes in
single channel conductance (Schreibmayer et al., 1987;
Kirsch et al., 1989; El-Sherif et al., 1992; Nagy, 1987),
but these studies measured currents early after depolar-
izations. To definitely exclude conductance changes
from playing a role in plateau current, single Na chan-
nel events were recorded in the cell-attached patch
configuration in control and with saturating concentra-
tions of toxin added to the pipette solution for both
channel isoforms. The control amplitude was then
compared with that of toxin-modified openings at late
times after depolarization onset. Because of the small
amplitude of the plateau current (5Ð17%), we typically
studied toxin-modified patches with large numbers of
channels. We found that modification by toxin left sin-
gle-channel conductance unaltered. In [Na]out 5 280
mM, conductances were as follows: cardiac control,
17.1  6  0.6 pS (n 5 3); cardiac toxin-modified, 17.6 6
1.7 pS (n 5 4); neuronal control, 23.7 6 2.7 pS (n 5 4);
neuronal toxin-modified, 21.9 6 1.2 pS (n 5 4). It
should be noted that, consistent with other reports
(Nagy, 1987; El-Sherif et al., 1992), toxin modification
also introduced occasional subconductances, particu-
larly in cardiac channels, which typically occurred at
the beginning or end of excursions to the primary con-
ductance (Fig. 4 A, arrow).
In the absence of toxin, channels typically inactivated
after opening at most a small number of times (Fig. 4,
A and C). In channels modified by toxin, however, this
behavior was replaced by initial clusters of multiple
openings, followed by periodic subsequent reopenings
throughout the duration of the recording (Fig. 4, B
and D). In accordance with the discrete, stochastic na-
ture of these reopenings, n*Po diaries constructed from
recordings of toxin-modified openings over 500Ð1,000
ms after the onset of depolarizations exhibited moder-
ate activity in a majority of sweeps (Fig. 4, EÐH). In con-
trast, if plateau current was produced through a rare,
modal failure of inactivation, n*Po diaries would have
contained long trains of openings in only a fraction of
sweeps, with accompanying occasional spikes on n*Po
diaries. Similar data were obtained in three cardiac
patches and three neuronal patches.
We employed two statistical techniques to support
the qualitative observation that persistent current did
not arise through a rare modal failure of inactivation.
First, we employed a runs analysis using the method of
Horn et al. (1984). If even one channel were to fail to
inactivate in any given sweep, the overall value of n*Po
during that sweep would be high. Therefore, we classi-
fied sweeps on the basis of aggregate n*Po activity, rat-
ing them as either above or below the mean value of
n*Po for that patch and voltage. We then evaluated for
a nonrandom association of high- or low-activity sweeps
using the published statistical criterion (Horn et al.,
1984). For the 27 data sets (six patches, four voltages
for neuronal patches and five voltages for cardiac
patches), only two sets showed any nonrandom activity
(P  ,  0.05; a N1E-115 patch in two of four voltages
tested, 25 and 225 mV). The remaining voltages of
this patch, as well as the data from the other five
patches analyzed in this manner, failed to show any
nonrandom intersweep patterns of activity.
Although the runs analysis failed to support the hy-
pothesis that plateau current arose from modal behav-
ior persistent across multiple sweeps, it did not address
the possibility that the persistent current arose from oc-
casional complete failures of channels to inactivate for
shorter duration; i.e., during single depolarizations. To
test for such patterns for each patch and voltage, we
constructed histograms that grouped sweeps by their
Figure 3. Steady state availability relations of cardiac (A) and
neuronal (B) channels in the absence (j) and presence (s) of
ApB. Toxin-modified current was recorded at a uniform time
point corresponding to the time to peak current in test pulses after
the most negative conditioning steps; peak currents were recorded
in control cells. (Inset) Voltage protocol. 2-s conditioning pulses
to the indicated voltages were followed by test pulses to 210 mV
(cardiac control, n 5 11; cardiac toxin, n 5 3; neuronal control,
n 5 5; neuronal toxin, n 5 3).339 Benzinger et al.
aggregate value of n*Po and fitted these histograms
with a gamma distribution (see, e.g., Johnston and Wu,
1995) (Fig. 4, E, F, and H, insets). Fits were possible for
data sets with .200 openings so that all neuronal data
and two data sets from RT4-B8 patches were analyzed.
Occasional failures of inactivation would be expected
to produce very high n*Po values outside the otherwise
smooth distribution of activities. To evaluate the extent
to which high n*Po sweeps exceeded what would be ex-
pected, we identified the tail of the fitted n*Po distribu-
tion that accounted for the 10% of the current pro-
duced by sweeps with the highest activity. We then com-
pared this with the calculated fraction of actual plateau
current produced in this high activity range. Averages
for all patches and voltages indicated that 94% of the
observed plateau current was explained by periodic,
discrete reopenings at late time periods. (Only 6 6 3%
of the plateau current comprised anomalously high
n*Po activity.) This analysis and the runs analysis above
effectively exclude occasional complete failures of inac-
tivation as a significant contributor to the observed pla-
teau current.
We next compared the mean open times of the late
reopenings to those of control channels. Mean open
times of late reopenings were similar to control open
times at mild depolarizations close to the activation
threshold, and they progressively increased with in-
creasing voltage (Fig. 5). This behavior was similar to
Figure 4. Persistent current
arises from late channel reopen-
ings. (AÐD) Single-channel cur-
rents arising from cardiac (A and
B) and neuronal (C and D)
channels in the absence (A and
C) and presence (B and D) of
saturating concentrations of
ApB. Contiguous traces are
shown in response to depolariza-
tions to 225 mV. Control
patches typically contained three
or fewer channels; patches in the
presence of toxin contained
many channels. (Arrow)  Brief
subconductance. (EÐH) n*Po dia-
ries of toxin-modified cardiac (E
and G) and neuronal (F and H)
channels with voltages as shown.
Diaries reflect activity from 500
to 1,000 ms after the onset of de-
polarization, and were calcu-
lated for each sweep as S(con-
ductance level * time)/S(time).
Bars in E and H mark the sweeps
depicted in B and D, respectively.
(Insets) Histograms of sweeps as
a function of n*Po activity.
(Curves) Best fits of histogram
data with gamma distributions.
The fraction of excess plateau
current in the high n*Po tails of
the histogram is (E) 210%, (F)
18%, and (H) 19%. The data
set shown in G lacked sufficient
openings to produce an accept-
able fit to histogram data.340 Site-3 Toxins Augment Recovery of Na Channels
that previously recorded from initial, early toxin-modi-
fied openings (Kirsch et al., 1989; El-Sherif et al.,
1992), suggesting that the durations of both early and
late events are influenced by the toxinÕs inhibition of
inactivation. Even though patches contained multiple
channels, overlapping events at late times were infre-
quent, as would be expected because of the low proba-
bility of channel reopenings. Particularly in cardiac
channels, late re-openings typically comprised of bursts
of several openings with brief closures that were some-
times poorly resolved. To address this possible con-
founding factor, we constructed histograms measuring
the total open time of bursts (defined as openings sepa-
rated by closures #3 ms). The mean duration of these
bursts also increased with progressive depolarization
(Fig. 5), implying that the observed voltage depen-
dence of mean open times was not an artifact of missed
closures.
Augmentation of Recovery
The presence of late reopenings separated by long
nonconducting periods suggested a model in which the
channelsÕ inactivated state(s) were destabilized; i.e., an
increase in the rate of recovery from inactivation. We
tested this conjecture by measuring whole-cell recovery
rates. In both cardiac (Fig. 6) and neuronal (Fig. 7)
channel isoforms, modification with ApB significantly
enhanced recovery in both isoforms over a range of po-
tentials. This effect was significant at all potentials, as
measured by the decrease in the dominant time con-
stant of recovery (Fig. 8, A and C).
One possible mechanism for this toxin-mediated en-
hancement might be the enhancement of a recovering
transition directly back to the open state (that is, the I
® O transition). Na channels do not normally recover
via this path (Kuo and Bean, 1994). However, the dem-
onstrated ability of these toxins to inhibit the O ® I
transition gives this prospect a pleasing symmetry. Dur-
ing recovery, inactivated Na channels must normally
move through several inactivated states before reaching
a state with an appreciable rate of return into the acti-
vation pathway (Scheme I; Chiu, 1977; Kuo and Bean,
1994). Thus, recovery proceeds after an initial delay, re-
flecting the time required for the channelÕs transit
through one or more inactivated states. This delay was
easily detectable for both channel isoforms in control
at the experimental temperature of 68C (Figs. 6 and 7,
insets). Previous data noted an absence of this delay in
toad myelinated nerve after channel modification
(Wang and Strichartz, 1985). Also, because of the exist-
ence of a toxin-induced plateau current that persisted
until the end of the inactivating prepulses, we expected
some INa even at very short recovery times. Therefore,
we were surprised to find that a delay persisted in toxin
before any channels, in addition to those already com-
prising the plateau current, recovered into the activa-
tion pathway. This delay was shorter than that found in
control channels and became undetectable only at the
most negative recovery voltages tested. This lag is
graphically evident in Figs. 6 B and 7 B (arrows) and is
quantified in Fig. 8, B and D.
The continued presence of a delay even when a frac-
tion of channels was open at the onset of the recovery
(scheme i)
Figure 5. Mean open times of single channel openings recorded
from cardiac (A) and neuronal (B) channels. Open-time histo-
grams were calculated from idealized traces of control patches
(j), and patches modified by ApB (s), and were fit with single ex-
ponentials. In toxin patches, only events arising from late reopen-
ings were included. Burst times (m) of toxin-modified patches
were taken from single exponential fits to burst-time histograms as
described in the text. Cardiac/toxin, n 5 4; cardiac/control, n 5
5; neuronal/toxin, n 5 4; neuronal/control, n 5 4. Two patches
from neuronal channels (one in control, one with toxin) displayed
greatly prolonged mean open times and were not included in this
analysis.341 Benzinger et al.
interval strongly argues against significant recovery of
channels through the open state at negative potentials.
To further verify that toxin did not augment recovery
directly into the open state, we recorded current dur-
ing the recovery process. That is, cells expressing car-
diac or neuronal channels were depolarized until inac-
tivation reached steady state and were allowed to re-
cover while current was recorded at high resolution.
The protocol is depicted in Fig. 9 A. In cells expressing
neuronal channels (Fig. 9 B), a current was present at
the onset of the recovery interval and it rapidly de-
cayed. We interpret this current as arising from chan-
nels open at the end of the conditioning prepulse con-
ducting current according to the increased driving
force at the recovery potential. The time constant of
this current decay (290 ms at 2100 mV in Fig. 9 B) was
much faster than the time constant of recovery from in-
activation (13.6 ms at 2100 mV, from Fig. 8 C) and was
similar to the time constant of deactivation of unmodi-
fied INa tail currents at 2100 mV for the same cell
shown in Fig. 9 B (240 ms, data not shown). The behav-
ior of cardiac channels was qualitatively similar (Fig. 9
C), but the smaller magnitude of the plateau current in
this isoform made the detection of current during re-
covery more difficult. In neither isoform was a discrete
current arising from recovering channels detectable
(see discussion).
discussion
In this study, we have demonstrated the existence of a
noninactivating plateau current in both cardiac and
neuronal isoforms of the voltage-gated Na channel
when modified by a high affinity site-3 sea anemone
toxin (Anthopleurin B). The voltage dependence of
the equilibrium distribution between nonconducting
and conducting states is biphasic. That is, toxin-modi-
fied channels reside entirely in closed states at negative
potentials (as do toxin-free channels), partition com-
pletely into inactivated states at intermediate voltages,
and occupy the open state with an appreciable proba-
bility at positive potentials. In this sense, our results ac-
cord strongly with those obtained from channels modi-
fied with a-scorpion toxins (Koppenhofer and Schmidt,
1968; Mozhayeva et al., 1980; Wang and Strichartz,
1985), where the steady state current relation also
showed a nadir at modest depolarizations. At first
glance, these results appear to conflict with a number
of other reports of toxin-modified channel availability.
An early study in the frog node of Ranvier with toxin II
from A. sulcata (Bergman et al., 1976) produced an
availability curve that reached zero, but the toxin con-
centrations used were near the Kd for the toxin/chan-
nels studied, probably leading to an underestimation of
the plateau current magnitude. A study of the action of
Leiurus toxin on N18 neuroblastoma cells also demon-
strated only a small plateau current, but these investiga-
Figure 6. Toxin enhances re-
covery from inactivation of car-
diac channels. After inactivation
to steady state at 0 mV for 1,500
ms, cells expressing cardiac chan-
nels with (s) or without (j) ex-
posure to ApB were allowed to
recover for the indicated times at
(A) 2145 and (B) 2100 mV. Raw
traces  show current during test
pulses after recovery times of 1, 4,
16, 64, 256, and 1,024 ms in the
presence (s) and absence (j)
of toxin. (Insets) Onset of recov-
ery on an expanded scale. (Ar-
row) Presence of a delay before
recovery onset at positive voltages
in the presence of toxin. (A) n 5
7, toxin; n 5 5, control. (B) n 5
5, toxin; n 5 3, control.342 Site-3 Toxins Augment Recovery of Na Channels
tors did not probe the relationship at positive poten-
tials (Gonoi et al., 1984). Likewise, the apparent com-
plete inactivation noted in canine cardiac myocytes
(Hanck and Sheets, 1995) undoubtedly arose because
of the low amplitude of the plateau current in that
channel isoform and the relatively negative voltage
range tested. On the other hand, the voltage-indepen-
dent plateau current noted by Wasserstrom et al.
(1993) probably reflects the steady state current at
their test potential (220 mV).
Analysis of single channel recordings revealed that
the plateau current arises from discrete, late channel
reopenings. These late events have kinetics similar to
early toxin-modified events and are separated by longer
closed intervals, and so appear to reflect an increase in
one or more of the rate constants in the recovery path-
way, a hypothesis also supported by the toxin-mediated
enhancement of whole-cell recovery from inactivation.
Consistent with these observations, two previous single-
channel studies reported that toxin treatment induced
a second, slow component into the first-latency distri-
bution of channel openings; that is, a subset of sweeps
showed activity in which channels first opened at dra-
matically late times after depolarization onset (Schreib-
mayer et al., 1987; Kirsch et al., 1989). These papers
did not consider the issue of late reopenings; however,
in light of these studies, this late component may repre-
sent channels that inactivate without opening upon de-
polarization onset, but later recover back into the acti-
vation pathway and open for the first time.
Site-3 toxins do not induce a modal shift in gating, as
evidenced by the relative homogeneity of the n*Po dia-
ries and failure of statistical analysis to detect modal ac-
tivity across or within sweeps. The suggestion of this ac-
tion by toxin II from A. sulcata in skeletal muscle Na
channels (Cannon and Corey, 1993) was probably a re-
sult of the low affinity for this toxin for skeletal muscle
channels, causing patches to be modified during only a
fraction of the sweeps.
These toxins are well known to have lower affinity for
inactivated than for resting or open channels (Catter-
all, 1979; Mozhayeva et al., 1980; Warashina and Fujita,
1983; Strichartz and Wang, 1986). In fact, for some
toxin/channel pairs, this can be dramatic and easily ob-
served (Strichartz and Wang, 1986). Consequently, we
considered whether dissociation of toxin during pro-
longed depolarization might occur. However, this pro-
cess was minimal in these experiments. First, the Na1
current induced by the toxins included a persistent cur-
rent that did not decay appreciably during a 1.5-s depo-
larization (see Fig. 1, A and B), a time comparable to
that of the longest conditioning pulse used in these
studies (2 s). By definition, therefore, toxin did not dis-
sociate significantly during this time interval. Second, if
Figure 7. Toxin enhances re-
covery from inactivation of neu-
ronal channels at (A) 2130 and
(B) 285 mV, see Fig. 6 for de-
tails. (A) n 5 4, toxin; n 5 4, con-
trol. (B) n 5 4, toxin; n 5 4, con-
trol.343 Benzinger et al.
toxin were to dissociate during extended conditioning
pulses, upon repolarization it could not rebind to chan-
nels at a rate any faster than that dictated by the known
toxin/channel association rates, which are slow (Khera
et al., 1995). For instance, N1E-115 channels in the
presence of 300 nM ApB (a commonly used concentra-
tion) would be expected to rebind toxin with a time
constant of 3.5 s, but after a depolarization channels
were fully modified at the earliest times channels re-
cover (e.g., 0.25 s in Fig. 7). Finally, we directly assayed
toxin dissociation by depolarizing toxin-modified neu-
ronal cells to 0 mV in toxin-free solution for 20 and 60 s,
and only 5.4 and 11.5% dissociation occurred. It is,
therefore, unlikely that the dissociation of toxin from
channels during depolarization affects the results.
Although there appear at first glance to be differ-
ences in the effect of toxin on INa from cardiac and
neuronal channels (compare, for example, Fig. 1, A
and B), these differences are most likely to be second-
ary to quantitative differences in the kinetics of the two
isoforms. In both isoforms, toxin binding appears to
augment the rate of recovery (compare Fig. 8, A and
C), shorten but not eliminate the delay before recovery
onset (compare Fig. 8, B and D), and produce a pla-
teau current comprising discrete late reopenings (com-
pare Fig. 4, B and D) with no evidence for modal inacti-
vation failure. The relatively prolonged mean open and
burst times found in cardiac channels as compared
with neuronal channels (Fig. 5) probably reflect only
differing rate constants in the activation pathway.
Taken together, modification by toxin in cardiac chan-
nels produces a plateau current of smaller magnitude,
comprising fewer, longer openings than in neuronal
cells, but arising through the same enhancement of re-
covery from inactivation as found in neuronal chan-
nels.
Analysis of recovery in whole-cell experiments dem-
onstrated that toxin speeds recovery at all potentials
and shortens the delay in recovery from inactivation. In
this regard, our data stand in contrast to those reported
Figure 8. Toxin enhances re-
covery from inactivation. Individ-
ual recovery diaries (as in Fig. 6)
were fit with an initial delay, fol-
lowed by a double exponential
approach. The faster time con-
stant is plotted for cardiac (A)
and neuronal (C) channels in the
presence (s) and absence (j) of
saturating toxin concentrations.
The slower time constant typi-
cally comprised z25% of the to-
tal amplitude in cardiac chan-
nels and 35% in neuronal chan-
nels, with a slightly higher
amplitude in toxin. It usually
ranged from 100Ð400 ms and was
somewhat faster in toxin-contain-
ing solutions. Although fits with
this function yielded reasonable
values for the duration of the ini-
tial delay, we achieved smaller er-
ror by defining the end of the de-
lay empirically as the time at
which current during the test
pulse had grown to 2% of its as-
ymptotic value at long recovery
times. Values obtained using this
objective criterion are shown for
cardiac (B) and neuronal (D)
channels. The grey box denotes
delay times #1 ms, below which
estimates of delay were unre-
liable because this was the first
time point recorded. No signifi-
cant delay could be measured at
the most negative potential inves-
tigated in  each isoform (2145
mV for cardiac and 2130 mV for
neuronal).344 Site-3 Toxins Augment Recovery of Na Channels
in toad myelinated nerve since in that preparation
toxin eliminated the delay before the onset of recovery
and did not change the time constant of current recov-
ery (Wang and Strichartz, 1985).
How might toxin treatment destabilize the channelsÕ
inactivated states and enhance macroscopic recovery?
The accepted existence of a delay before the onset of
recovery in Na channels (Kuo and Bean, 1994) strongly
suggests the presence of multiple inactivated states. In
light of this observation, several kinetic modifications
might produce the observed enhancement in recovery.
First, toxins might augment the rate of recovery into
the open state (Scheme II, 1). Second, toxins might en-
hance one or more of the existing rates of channel re-
covery to closed, available states (Scheme II, 2). Third,
toxins might simply enhance one or more deactivating
(i.e., ÒleftwardÓ) transition rates between the multiple
inactivated states, bringing channels more quickly into
inactivated states from which recovery rates are high
(Scheme II, 3). Finally, the action of toxin might of
course comprise a combination of these effects. Site-3
toxins are already known to decrease the rate of Na
channel inactivation from the open state, O ® I
(Schreibmayer et al., 1987; Nagy, 1988; Kirsch et al.,
1989; El-Sherif et al., 1992; Hanck and Sheets, 1995;
Sheets and Hanck, 1995). Therefore, it is tempting to
hypothesize that the plateau current at positive voltages
represents an O « I equilibration that partially favors
the open state, and we can predict quantitative bound-
aries on the unidirectional rate constants of O ® I and
I ® O.
The rate of decay of macroscopic Na1 current after
toxin modification is remarkably voltage independent.
In neuronal channels treated with saturating ApB, sin-
gle exponential fits to the decaying phase of current
transients yielded a time constant of 31.4 6 0.4 ms, in-
variant over a range of 225 to 130 mV (n 5 5). At the
positive end of this voltage range, the majority of chan-
nels are likely to be found in either the open state or
the distal-most inactivated state. The reciprocal of this
time constant can, therefore, be taken as representing
the rate of equilibration between these two conforma-
tions (kOI 1 kIO). The O « I equilibrium places 17%
(plateau amplitude at $120 mV in Fig. 2) of the chan-
nels in the open state [kIO/(kOI 1 kIO)]. Thus, kOI is cal-
culated to be 26 s21, and kIO is calculated as 5 s21. This
rate of I ® O transitions is significantly slower than the
observed macroscopic rate of recovery from inactiva-
tion in toxin-modified N1E-115 cells (see Fig. 8 C). Even
in the presence of toxin, therefore, channels at nega-
tive voltages more likely recover by traversing multiple
inactivated states before returning to one of the closed
states. Consistent with this conclusion, a delay in recov-
ery from inactivation continues to be measurable ex-
cept at the most negative voltages (see Fig. 8, B and D).
The issue of channel recovery through the open state
during repolarization can also be addressed by the time
course of current present during recovery from inacti-
vation. We can evaluate the contribution of kIO by simu-
lation using an irreversible, simplified Markov model of
the recovery process (Fig. 10), using rate constants
based on the experimental data from neuronal chan-
nels. The closing rate (kOC) was taken from the time
constant of tail currents in the absence of toxin (at
2100 mV), and the rate of recovery (kIC) was taken
(scheme ii)
Figure 9. Recovering channels do not carry appreciable current.
(A) Voltage protocol. Channels were inactivated to steady state at
0 mV. Channels were then allowed to recover at the indicated volt-
ages, during which any current through open channels was re-
corded. A subsequent test pulse to 0 mV confirmed channel recov-
ery. (B) Recovery from inactivation of neuronal channels. A sub-
stantial tail current is present during the recovery interval. (Inset)
The beginning of the recovery interval on expanded time and cur-
rent axes (cell 98211038, Rm 5 0.6 GV). (C) Recovery from inacti-
vation of cardiac channels at the indicated voltages (cell 97d11012,
Rm 5 0.7 GV).345 Benzinger et al.
from the average rate of recovery at 2100 mV in the ab-
sence of toxin. The form of the current during recov-
ery depends on the relative magnitude of the rate con-
stant between I and O (kIO) compared with kOC and kIC.
If  kIO is similar to the rate of deactivation (kOC), a
ÒhookedÓ current will appear during recovery, reflect-
ing the accumulation of channels in O (e.g., kIO  5
1,500). If kIO is slower than kOC but still faster than kIC,
then current will decay with an apparent exponential,
but the time constant of this exponential will approxi-
mate the overall time constant of recovery (e.g., kIO 5
500). If kIO is slow, but still sufficiently large to cause ap-
preciable recovery through the open state (e.g., kIO 5
77), then current decay will comprise two obvious com-
ponents: a rapid deactivation and a much slower decay
corresponding to recovering channels.
The observed behavior (e.g., Fig. 9 B, 2100 mV)
shows a complete exponential decay of current that is
rapid in comparison to the rate of whole-cell recovery,
which is similar to that expected when kIO is low (e.g.,
Fig. 10, 18 s21) or nonexistent (Fig. 10, dotted line).
In summary, therefore, it appears that the plateau
current produced in the presence of toxin arises from
an O « I equilibrium that partially favors the open
state, but that the overall rate of I ® O recovery is still
not sufficiently large to cause appreciable numbers of
channels to recover through the open state during re-
polarization. Nonetheless, toxin treatment does aug-
ment recovery from inactivation. We suggest that both
of these observations can be parsimoniously rational-
ized under the assumption that the toxin destabilizes
the terminal inactivated state of the channel. Open-
state inactivation is slowed (Schreibmayer et al., 1987;
Nagy, 1988; Kirsch et al., 1989; El-Sherif et al., 1992),
producing the well-known prolongation of macro-
scopic inactivation and increase in mean open time.
This slowing, combined with a possible augmentation
of the open-state recovery rate I ® O, produces the ob-
served plateau current. Finally, destabilization of the fi-
nal inactivated state augments the leftward I ¬ I transi-
tion, enhancing recovery and shortening the delay be-
fore recovery onset.
This hypothesis accounts for all of the observed ki-
netic features of this toxin through destabilization of a
single kinetic state of the channel, raising the possibil-
ity that this toxin can be used to define the molecular
determinants of a specific kinetic state. Such a molecu-
lar identification has not been previously possible, and
it would be an important step towards reconciling ki-
netic models with gross channel conformation.
Figure 10. Model of recovery through the open state. An irre-
versible, three-state Markov model was constructed with rate con-
stants picked as described in the text. Initial occupancies were [O]
5 0.22 and [I] 5 0.78. Dotted line represents the single-exponen-
tial course of current deactivation with kIO 5 0. 
references 
Ackerman, M.J. 1998. The long QT syndrome: ion channel diseases
of the heart. Mayo Clin. Proc. 73:250Ð269.
Aldrich, R.W., D.P. Corey, and C.F. Stevens. 1983. A reinterpreta-
tion of mammalian sodium channel gating based on single chan-
nel recording. Nature. 306:436Ð441.
Alzheimer, C., P.C. Schwindt, and W.E. Crill. 1993. Modal gating of
Na1 channels as a mechanism of persistent Na1 current in pyra-
midal neurons from rat and cat sensorimotor cortex. J. Neurosci.
13:660Ð673.
Bergman, C., J.M. Dubois, E. Rojas, and W. Rathmayer. 1976. De-
creased rate of sodium conductance inactivation in the node of
Ranvier induced by a polypeptide toxin from sea anemone. Bio-
chim. Biophys. Acta. 455:173Ð184.
Berman, M.F., J.S. Camardo, R.B. Robinson, and S.A. Siegelbaum.
1989. Single sodium channels from canine ventricular myocytes:
voltage dependence and relative rates of activation and inactiva-
tion. J. Physiol. (Lond.). 415:503Ð531.
Cannon, S.C. 1996. Ion-channel defects and aberrant excitability in
myotonia and periodic paralysis. Trends Neurosci. 19:3Ð10.
Cannon, S., and D. Corey. 1993. Loss of Na1 channel inactivation
by anemone toxin (ATX II) mimics the myotonic state in hyper-
kalaemic periodic paralysis. J. Physiol. (Lond.). 466:501Ð520.
We thank Kenneth Blumenthal for providing the recombinant ApB toxin. We thank Jack Kyle and Ruth Martin for their on-
going contributions to our research, and Michael Sheets (University of Utah, Salt Lake City, UT) for his critical reading of the
manuscript. 
This study was supported by National Heart, Lung and Blood Institute grant HL-PO1-20592 (D.A. Hanck) and an American
Heart Association Established Investigatorship (D.A. Hanck). G.R. Benzinger is a trainee of the Medical Scientist Training Pro-
gram (5-T32-GM07281).
Original version received 8 September 1998 and accepted version received 10 December 1998.346 Site-3 Toxins Augment Recovery of Na Channels
Catterall, W.A. 1977. Activation of the action potential Na1 iono-
phore by neurotoxins. J. Biol. Chem. 252:8669Ð8676.
Catterall, W. 1979. Binding of scorpion toxin to receptor sites associ-
ated with sodium channels in frog muscle. J. Gen. Physiol. 74:375Ð391.
Catterall, W. 1980. Neurotoxins that act on voltage-sensitive sodium
channels in excitable membranes. Annu. Rev. Pharmacol. Toxicol.
20:15Ð43.
Chiu, S.Y. 1977. Inactivation of sodium channels: second order ki-
netics in myelinated nerve. J. Physiol. (Lond.). 273:573Ð596.
Dib-Hajj, S.D., A.W. Hinson, J.A. Black, and S.G. Waxman. 1996.
Sodium channel mRNA in the B104 neuroblastoma cell line.
FEBS Lett. 384:78Ð82.
Donahue, L.M., K. Schaller, and N. Sueoka. 1991. Segregation of
Na-channel gene expression during neuronal-glial branching of
a rat PNS-derived stem cell line, RT4-AC. Dev. Biol. 147:415Ð424.
El-Sherif, N., H.A. Fozzard, and D.A. Hanck. 1992. Dose-dependent
modulation of the cardiac sodium channel by sea anemone toxin
ATXII. Circ. Res. 70:285Ð301.
Fozzard, H.A., and D.A. Hanck. 1996. Structure and function of
voltage-dependent sodium channels: comparison of brain II and
cardiac isoforms. Physiol. Rev. 76:887Ð926.
Goldman, L. 1995. Sodium channel inactivation from closed states:
evidence for an intrinsic voltage dependency. Biophys. J. 69:2369Ð
2377.
Gonoi, T., B. Hille, and W.A. Catterall. 1984. Voltage clamp analy-
sis of sodium channels in normal and scorpion toxinÐresistant
neuroblastoma cells. J. Neurosci. 4:2836Ð2842.
Hanck, D.A., and M.F. Sheets. 1995. Modification of inactivation in
cardiac sodium channels: ionic current studies with anthopleu-
rin-A toxin. J. Gen. Physiol. 106:601Ð616.
Horn, R., C.A. Vandenberg, and K. Lange. 1984. Statistical analysis
of single sodium channels: effects of n-bromoacetamide. Biophys. J.
45:323Ð335.
Johnston, D., and S.M. Wu. 1995. Foundations of Cellular Neuro-
physiology. MIT Press, Cambridge, MA. p. 298.
Khera, P.K., G.R. Benzinger, G. Lipkind, C.L. Drum, D.A. Hanck,
and K.M. Blumenthal. 1995. Multiple cationic residues of Antho-
pleurin B that determine high affinity and channel isoform dis-
crimination. Biochemistry. 34:8533Ð8541.
Kirsch, G.E., A. Skattebol, L.D. Possani, and A.M. Brown. 1989.
Modification of Na channel gating by an alpha scorpion toxin
from Tityus serrulatus. J. Gen. Physiol. 93:67Ð83.
Koppenhofer, E., and H. Schmidt. 1968. Effect of scorpion venom
on ionic currents in the node of Ranvier. II. Incomplete sodium
inactivation. Pflgers Arch. 303:150Ð161.
Kuo, C.-C., and B.P. Bean. 1994. Na1 channels must deactivate to
recover from inactivation. Neuron. 12:819Ð829.
Mozhayeva, G.N., A.P. Naumov, E.D. Nosyreva, and E.V. Grishin.
1980. Potential-dependent interaction of toxin from venom of
the scorpion Buthus eupeus with sodium channels in myelinated
fibre. Biochim. Biophys. Acta. 597:587Ð602.
Nagy, K. 1987. Subconductance states of single sodium channels
modified by chloramine-T and sea anemone toxin in neuroblas-
toma cells. Eur. Biophys. J. 15:129Ð132.
Nagy, K. 1988. Mechanism of inactivation of single sodium chan-
nels after modification by chloramine-T, sea anemone toxin and
scorpion toxin. J. Membr. Biol. 106:29Ð40.
Narahashi, T., J.W. Moore, and B.I. Shapiro. 1969. Condylactis
toxin: interaction with nerve membrane ionic conductances. Sci-
ence. 163:680Ð681.
Patlak, J.B., and M. Ortiz. 1985. Slow currents through single so-
dium channels of the adult rat heart. J. Gen. Physiol. 86:89Ð104.
Romey, G., J.P. Abita, H. Schweitz, G. Wunderer, and M. Lazdun-
ski. 1976. Sea anemone toxin: a tool to study molecular mecha-
nisms of nerve conduction and excitationÐsecretion coupling.
Proc. Natl. Acad. Sci. USA. 73:4055Ð4059.
Scanley, B.E., D.A. Hanck, T. Chay, and H.A. Fozzard. 1990. Kinetic
analysis of single sodium channels from canine cardiac Purkinje
cells. J. Gen. Physiol. 95:411Ð435.
Schreibmayer, W., H. Kazerani, and H.A. Tritthart. 1987. A mecha-
nistic interpretation of the action of toxin II from Anemonia sul-
cata on the cardiac sodium channel. Biochim. Biophys. Acta. 901:
273Ð282.
Sheets, M.F., and D.A. Hanck. 1995. Voltage-dependent open-state
inactivation of cardiac sodium channels: gating current studies
with Anthopleurin-A toxin. J. Gen. Physiol. 106:617Ð640.
Siemen, D., and W. Vogel. 1983. Tetrodotoxin interferes with the
reaction of scorpion toxin (Buthus tamulus) at the sodium chan-
nel of the excitable membrane. Pflgers Arch. 397:306Ð311.
Strichartz, G., and G.K. Wang. 1986. Rapid voltage-dependent dis-
sociation of scorpion alpha-toxins coupled to Na channel inacti-
vation in amphibian myelinated nerves. J. Gen. Physiol. 88:413Ð435.
Strichartz, G., T. Rando, and G.K. Wang. 1987. An integrated view
of the molecular toxinology of sodium channel gating in excit-
able cells. Annu. Rev. Neurosci. 10:237Ð267.
Vandenberg, C.A., and F. Bezanilla. 1991. A sodium channel gating
model based on single channel, macroscopic ionic, and gating
currents in the squid giant axon. Biophys. J. 60:1511Ð1533.
Wang, G.K., and G.R. Strichartz. 1983. Purification and physiologi-
cal characterization of neurotoxins from venoms of the scorpi-
ons Centruroides sculpturatus and Leiurus quinquestriatus. Mol. Phar-
macol. 23:519Ð533.
Wang, G.K., and G. Strichartz. 1985. Kinetic analysis of the action
of Leiurus alpha-toxin on ionic currents in myelinated nerve. J.
Gen. Physiol. 86:739Ð762.
Warashina, A., and S. Fujita. 1983. Effects of sea anemone toxins on
the sodium inactivation process in crayfish axons. J. Gen. Physiol.
81:305Ð323.
Wasserstrom, J.A., J.E. Kelly, and K.N. Liberty. 1993. Modification
of cardiac Na1 channels by Anthopleurin-A: effects on gating
and kinetics. Pflgers Arch. 424:15Ð24.
Yue, D.T., J.H. Lawrence, and E. Marban. 1989. Two molecular
transitions influence cardiac sodium channel gating. Science. 244:
349Ð352.
Zeng, D.W., J.W. Kyle, R.L. Martin, K.S. Ambler, and D.A. Hanck.
1996. Cardiac sodium channels expressed in a peripheral neuro-
tumor-derived cell line, RT4-B8. Am. J. Physiol. 270:C1522ÐC1531.